Population
Mouse model of Staphylococcus aureus arthritis
Design
Preclinical
Follow-up
Up to 3 weeks
Authors
Loading...
This rapid mouse model of S. aureus arthritis leaves open its utility for preclinical therapeutic testing; human validation required before clinical relevance.
A newly developed mouse model of Staphylococcus aureus arthritis demonstrates rapid joint destruction and serological responses that closely resemble human septic arthritis, providing a platform for future pathogenetic and therapeutic studies.
Bremell et al. (1992) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: